Dividendenpolitik
BB Biotech combines long-term capital appreciation with attractive and sustainable shareholder returns. Since 2013 BB Biotech has paid an annual dividend across multiple market cycles, demonstrating its long-standing commitment to delivering value to shareholders. Effective from the 2026 financial year, BB Biotech's refined dividend policy aligns shareholder distributions more closely with long-term investment performance. At the same time, it provides the Board of Directors with greater flexibility to retain capital and deploy it into particularly attractive investment opportunities when appropriate.
3–5% target dividend yield
The Board of Directors determines the annual dividend yield within a target range of 3–5%.
Long-term value creation
The payout policy aligns shareholder distributions more closely with investment performance while maintaining flexibility for future investment opportunities.
Consistent distributions since 2013
BB Biotech has paid a regular annual dividend for more than a decade, across multiple market cycles.
Dividend development
| Jahr | Dividend/Cash distribution in CHF |
|---|---|
| 2026 | 2.25 |
| 2025 | 1.80 |
| 2024 | 2.00 |
| 2023 | 2.85 |
| 2022 | 3.85 |
How do dividends work?
Determination
Each year, the Board of Directors determines the dividend yield within the target range of 3–5%, taking into account investment performance, NAV development and prevailing market conditions.
Calculation
The dividend is calculated based on the volume-weighted average share price (VWAP) over a 20 trading-day period spanning late January and early February.
Distribution
The proposed dividend is submitted for shareholder approval at the Annual General Meeting and is generally paid in March.
Sustainable Value Creation for Shareholders
Performance-aligned
The dividend policy aligns shareholder distributions more closely with BB Biotech's long-term investment performance.
Sustainable
The 3–5% target range enables attractive shareholder distributions across different market environments.
Long-term
In periods of particularly attractive investment opportunities, additional capital can be retained within the portfolio to support future long-term value creation for shareholders.
3-5%
Targed dividend yield annualized